Lupin launches Tolvaptan Tablets in the US with 180-day exclusivity

Tolvaptan Tablets are indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease

Dr. Morepen launches Rs. 499 annual multivitamin pack on Labour’s Day

Priced at just Rs. 499 for 1-year supply, this initiative is aligned with the vision of Health for All

Mankind unveils HealthOK’s 100% vegetarian multivitamin tablets campaign with Archana Puran Singh

Clariant unveils natural preservation blend for cosmetics 'Nipaguard SCE Vita'

Nipaguard SCE Vita delivers comprehensive antimicrobial protection for personal care formulations

Fermenta's plant-based Vitamin D3 is 'Innovation of the Year'

VITADEETM Green is a 100% plant-based Vitamin D3 suitable for food & nutraceuticals

Bristol Myers Squibb Provides Update on Phase 3 RELATIVITY-098 Trial

The safety profile of Opdualag observed in this analysis was consistent with the known profiles of nivolumab and relatlimab

Brenntag Specialties unveils pharmaceutical and nutraceutical innovations at Vitafoods India

The company will showcase groundbreaking innovations from its Pharma and Nutrition divisions, highlighting key ingredients and formulations designed to support holistic well-being

Merieux completes acquisition of Bureau Veritas' food testing activities in Canada and US

The transaction is part of a broader agreement with Bureau Veritas covering its worldwide food laboratory testing activities

NTC presents positive results from Phase II Mirakle study evaluating an innovative drug for bacterial conjunctivitis

Despite NTC014, due to its simplified therapeutic regimen, has been administered at a lower posology than the antibiotic comparator

Roche’s fenebrutinib demonstrated near-complete suppression of disease activity and disability progression

New Phase II data show vast majority of patients experiencing no relapses or disability progression